No Prescription |
 |
 | ||
|
DILATREND Coreg |
|
| ||
No Prescription » Prescription Drugs 6 » DILATREND Coreg Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Dilatrend lowers blood pressure and increases the output of the heart. It is prescribed for people with congestive heart failure to increase survival and reduce the need for hospitalization. Dilatrend may be prescribed if you have survived a heart attack and now suffer from left ventricular dysfunction a condition where the left side of the heart no longer pumps properly. It is also used to control high blood pressure. It is often used with other drugs.Carvedilol is in a group of drugs called beta-blockers. Beta-blockers affect the heart and circulation (blood flow through arteries and veins).Carvedilol is used to treat heart failure and hypertension (high blood pressure). It is also used to treat or prevent heart attack.Treating high blood pressure or certain types of heart failure. It may also be used after a heart attack to improve survival in certain patients. It may be used along with other medicines. It may also be used for other conditions as determined by your doctor.Carvedilol is an alpha- and beta-blocker. It works by relaxing the blood vessels slowing down the heart and decreasing the amount of blood it pumps out. This decreases blood pressure helps the heart pump more efficiently and reduces the workload on the heart. Buy DILATREND Coreg and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About DILATREND Coreg: Product Type: Prescription Drugs 6 DILATREND ( Coreg Coreg CR Generic Carvedilol ) DILATREND (Coreg Coreg CR Generic Carvedilol) Coreg Coreg CR Generic Carvedilol 25mg 30 Tabs 6.250mg 90 Tablets 30 Tablets Coreg Coreg CR Generic Carvedilol DILATREND
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
